XML 12 R5.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit [Member]
Beginning Balance, Values at Dec. 31, 2023 $ 250,556 $ 78 $ 823,029 $ (52) $ (572,499)
Beginning Balance, Shares at Dec. 31, 2023   78,369,099      
Exercise of stock options 217   217    
Exercise of stock options, Shares   105,526      
Issuance of common stock, net of issuance costs, Value 32,198 $ 7 32,191    
Issuance of common stock, net of issuance costs, Shares   6,639,348      
Exercise of pre-funded warrants, Value   $ 5 (5)    
Exercise of pre-funded warrants, Shares   5,243,400      
Restricted stock vested in the period   124,695      
Stock-based compensation 4,660   4,660    
Other comprehensive loss (50)     (50)  
Net loss (25,176)       (25,176)
Ending Balance, Values at Mar. 31, 2024 262,405 $ 90 860,092 (102) (597,675)
Ending Balance, Shares at Mar. 31, 2024   90,482,068      
Beginning Balance, Values at Dec. 31, 2023 250,556 $ 78 823,029 (52) (572,499)
Beginning Balance, Shares at Dec. 31, 2023   78,369,099      
Net loss (54,786)        
Ending Balance, Values at Jun. 30, 2024 361,079 $ 106 988,347 (89) (627,285)
Ending Balance, Shares at Jun. 30, 2024   105,539,683      
Beginning Balance, Values at Mar. 31, 2024 262,405 $ 90 860,092 (102) (597,675)
Beginning Balance, Shares at Mar. 31, 2024   90,482,068      
Exercise of stock options 171   171    
Exercise of stock options, Shares   35,914      
Issuance of common stock per Employee Stock Purchase Plan purchase, Value 215 $ 1 214    
Issuance of common stock per Employee Stock Purchase Plan purchase, Shares   98,534      
Issuance of common stock, net of issuance costs, Value 6,126 $ 1 6,125    
Issuance of common stock, net of issuance costs, Shares   936,719      
Issuance of common stock and pre-funded warrants, net of issuance costs, Value 116,817 $ 13 116,804    
Issuance of common stock and pre-funded warrants, net of issuance costs, Shares   13,001,120      
Exercise of pre-funded warrants, Value   $ 1 (1)    
Exercise of pre-funded warrants, Shares   965,427      
Exercise of common warrants, Shares   19,901      
Stock-based compensation 4,942   4,942    
Other comprehensive loss 13     13  
Net loss (29,610)       (29,610)
Ending Balance, Values at Jun. 30, 2024 361,079 $ 106 988,347 (89) (627,285)
Ending Balance, Shares at Jun. 30, 2024   105,539,683      
Beginning Balance, Values at Dec. 31, 2024 293,105 $ 109 1,003,685 10 (710,699)
Beginning Balance, Shares at Dec. 31, 2024   109,381,556      
Exercise of stock options 62   62    
Exercise of stock options, Shares   43,113      
Restricted stock vested in the period   289,735      
Stock-based compensation 5,078   5,078    
Other comprehensive loss (101)     (101)  
Net loss (54,356)       (54,356)
Ending Balance, Values at Mar. 31, 2025 243,788 $ 109 1,008,825 (91) (765,055)
Ending Balance, Shares at Mar. 31, 2025   109,714,404      
Beginning Balance, Values at Dec. 31, 2024 $ 293,105 $ 109 1,003,685 10 (710,699)
Beginning Balance, Shares at Dec. 31, 2024   109,381,556      
Exercise of stock options, Shares 43,113        
Net loss $ (103,512)        
Ending Balance, Values at Jun. 30, 2025 199,017 $ 110 1,013,211 (93) (814,211)
Ending Balance, Shares at Jun. 30, 2025   109,832,147      
Beginning Balance, Values at Mar. 31, 2025 243,788 $ 109 1,008,825 (91) (765,055)
Beginning Balance, Shares at Mar. 31, 2025   109,714,404      
Issuance of common stock per Employee Stock Purchase Plan purchase, Value 182 $ 1 181    
Issuance of common stock per Employee Stock Purchase Plan purchase, Shares   117,743      
Stock-based compensation 4,205   4,205    
Other comprehensive loss (2)     (2)  
Net loss (49,156)       (49,156)
Ending Balance, Values at Jun. 30, 2025 $ 199,017 $ 110 $ 1,013,211 $ (93) $ (814,211)
Ending Balance, Shares at Jun. 30, 2025   109,832,147